CES1 and Huntington disease: We examined IL-6 levels in plasma obtained from HD and non-HD individuals, assessed IL-6 levels and endocannabinoid-metabolizing enzyme activity in PBMCs isolated from HD and non-HD individuals that were stimulated with inflammogens, and characterized the expression of MAGL and CES1 in PBMCs using immunoblot and flow cytometry.